Skip to main content

Arbutus Biopharma Corp

ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001447028

No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Arbutus Biopharma Corp as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
166
+4 vs. Q2 2025
Shares held
118.2M
+75.0K (+0.1%) vs. Q2 2025
Total value
$536.4M
+$171.5M (+47.0%) vs. Q2 2025
New holders
21
51 more added
Sold out
17
54 more reduced

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 166 institutions
Q1 2021: 94 institutionsQ2 2021: 91 institutionsQ3 2021: 100 institutionsQ4 2021: 123 institutionsQ1 2022: 119 institutionsQ2 2022: 113 institutionsQ3 2022: 127 institutionsQ4 2022: 114 institutionsQ1 2023: 122 institutionsQ2 2023: 111 institutionsQ3 2023: 99 institutionsQ4 2023: 112 institutionsQ1 2024: 119 institutionsQ2 2024: 131 institutionsQ3 2024: 144 institutionsQ4 2024: 154 institutionsQ1 2025: 168 institutionsQ2 2025: 163 institutionsQ3 2025: 166 institutionsQ4 2025: 172 institutionsQ1 2026: 167 institutionsQ2 2026: 176 institutions
Value heldQ3 2025: $536.4M
Q1 2021: $86.5MQ2 2021: $87.6MQ3 2021: $149.8MQ4 2021: $154.4MQ1 2022: $130.6MQ2 2022: $120.0MQ3 2022: $89.1MQ4 2022: $126.3MQ1 2023: $189.3MQ2 2023: $152.4MQ3 2023: $143.8MQ4 2023: $197.4MQ1 2024: $215.2MQ2 2024: $298.4MQ3 2024: $389.2MQ4 2024: $340.3MQ1 2025: $390.1MQ2 2025: $365.0MQ3 2025: $536.4MQ4 2025: $586.9MQ1 2026: $625.4MQ2 2026: $674.9M
Institutions holding ABUS and their total value by quarter
QuarterHoldersValue
Q2 2026176$674.9M
Q1 2026167$625.4M
Q4 2025172$586.9M
Q3 2025166$536.4M
Q2 2025163$365.0M
Q1 2025168$390.1M
Q4 2024154$340.3M
Q3 2024144$389.2M
Q2 2024131$298.4M
Q1 2024119$215.2M
Q4 2023112$197.4M
Q3 202399$143.8M
Q2 2023111$152.4M
Q1 2023122$189.3M
Q4 2022114$126.3M
Q3 2022127$89.1M
Q2 2022113$120.0M
Q1 2022119$130.6M
Q4 2021123$154.4M
Q3 2021100$149.8M
Q2 202191$87.6M
Q1 202194$86.5M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q2 2025.

Institutions holding ABUS in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Exome Asset Management LLC75,484$342.7K0.23%00.0%Unchanged
Man Group plc79,374$360.4K0.00%+40,377+103.5%Added
ExodusPoint Capital Management, LP82,377$374.0K0.01%+1,302+1.6%Added
Price T Rowe Associates Inc83,008$377.0K0.00%+6,485+8.5%Added
MetLife Investment Management87,850$398.8K0.00%−916−1.0%Reduced
FMR LLC89,464$406.2K0.00%+8,723+10.8%Added
BNP Paribas Arbitrage, SA89,899$408.1K0.00%+33,948+60.7%Added
Wells Fargo & Company95,451$433.3K0.00%+14,983+18.6%Added
JPMorgan Chase & Co98,229$446.0K0.00%+12,152+14.1%Added
Nomura Holdings Inc100,000$454.0K0.00%+3,720+3.9%Added
Zurcher Kantonalbank (Zurich Cantonalbank)100,338$455.5K0.00%00.0%Unchanged
Balyasny Asset Management LLC107,665$488.8K0.00%+107,665New
Wealth Management Associates, Inc.112,820$512.2K0.18%+7,900+7.5%Added
Schroder Investment Management Group121,313$541.1K0.00%00.0%Unchanged
Legal & General Group Plc124,177$563.8K0.00%−309−0.2%Reduced
California State Teachers Retirement System131,468$596.9K0.00%−1,290−1.0%Reduced
Deutsche Bank AG131,824$598.5K0.00%+18,118+15.9%Added
Alliancebernstein L.P.143,870$653.2K0.00%+23,630+19.7%Added
Arrowstreet Capital, Limited Partnership159,118$722.4K0.00%+159,118New
D. E. Shaw & Co., Inc.189,952$862.4K0.00%+149,252+366.7%Added
Citadel Advisors LLC193,691$879.4K0.00%+73,419+61.0%Added
Citigroup Inc197,838$898.2K0.00%−31,976−13.9%Reduced
Murchinson Ltd.200,000$908.0K0.18%+200,000New
StemPoint Capital LP205,388$932.5K0.19%+205,388New
Invesco Ltd.209,638$951.8K0.00%+28,554+15.8%Added
Rhumbline Advisers211,784$961.5K0.00%+3,979+1.9%Added
Qube Research & Technologies Ltd215,041$976.3K0.00%−152,989−41.6%Reduced
Royal Bank of Canada236,829$1.07M0.00%−30,358−11.4%Reduced
Nuveen, LLC257,934$1.17M0.00%−153,322−37.3%Reduced
Swiss National Bank276,300$1.25M0.00%00.0%Unchanged
Ledgewood Wealth Advisors, LLC278,436$1.26M0.75%00.0%Unchanged
Barclays PLC284,330$1.29M0.00%−122,228−30.1%Reduced
Jane Street Group, LLC300,455$1.36M0.00%+77,659+34.9%Added
Boothbay Fund Management, LLC310,051$1.41M0.04%+47,774+18.2%Added
Bank of New York Mellon Corp399,148$1.81M0.00%+32,796+9.0%Added
Freestone Capital Holdings, LLC442,500$2.01M0.06%00.0%Unchanged
Kennedy Capital Management, Inc.505,099$2.29M0.05%+55,920+12.4%Added
Western Standard LLC507,853$2.31M1.23%+507,853New
Wellington Management Group LLP514,083$2.33M0.00%−17,468−3.3%Reduced
Quinn Opportunity Partners LLC514,513$2.34M0.17%+50,000+10.8%Added
Millennium Management LLC528,340$2.40M0.00%+28,857+5.8%Added
Saba Capital Management, L.P.678,771$3.08M0.10%−581,358−46.1%Reduced
Bank of Montreal765,263$3.47M0.00%+164,833+27.5%Added
UBS Group AG774,594$3.52M0.00%+584,386+307.2%Added
Standard Life Aberdeen plc799,979$3.63M0.01%−182,548−18.6%Reduced
Hudson Bay Capital Management LP800,000$3.63M0.02%−165,000−17.1%Reduced
Rangeley Capital, LLC840,000$3.81M3.58%−25,000−2.9%Reduced
FourWorld Capital Management LLC1,020,910$4.63M11.23%−205,800−16.8%Reduced
Charles Schwab Investment Management Inc1,274,833$5.79M0.00%+21,004+1.7%Added
Northern Trust Corp1,289,413$5.85M0.00%+5,194+0.4%Added
Advisor Group Holdings, Inc.1,338,503$5.97M0.01%−130.0%Reduced
Bank of America Corp1,450,822$6.59M0.00%+253,167+21.1%Added
Rubric Capital Management LP1,575,376$7.15M0.10%00.0%Unchanged
Foursixthree Capital LP1,978,975$8.98M3.15%−578,392−22.6%Reduced
BlackBarn Capital Partners LP2,000,000$9.08M2.96%−603,521−23.2%Reduced
Woodline Partners LP2,165,602$9.83M0.05%−332,382−13.3%Reduced
Goldman Sachs Group Inc2,173,430$9.87M0.00%−866,353−28.5%Reduced
ADAR1 Capital Management, LLC2,903,226$13.2M1.31%+77,453+2.7%Added
Geode Capital Management, LLC3,666,162$16.6M0.00%+29,141+0.8%Added
State Street Corp4,098,318$18.6M0.00%−361,444−8.1%Reduced
Adage Capital Partners GP, L.L.C.5,014,941$22.8M0.04%+2,439,000+94.7%Added
Vanguard Group Inc8,991,082$40.8M0.00%−94,004−1.0%Reduced
Two Seas Capital LP10,991,261$49.9M3.00%+547,944+5.2%Added
BlackRock, Inc.12,677,496$57.6M0.00%−191,790−1.5%Reduced
Whitefort Capital Management, LP13,343,228$60.6M20.05%00.0%Unchanged
Morgan Stanley24,450,612$111.0M0.01%+288,229+1.2%Added
UBS Asset Management Americas Inc0$00.00%−1,072,744−100.0%Sold out
Eisler Capital Management Ltd.0$00.00%−276,375−100.0%Sold out
Franklin Resources Inc0$00.00%−104,423−100.0%Sold out
Caption Management, LLC0$00.00%−41,866−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−19,655−100.0%Sold out
Axq Capital, LP0$00.00%−18,545−100.0%Sold out
Colony Group, LLC0$00.00%−17,821−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−14,000−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−13,900−100.0%Sold out
LPL Financial LLC0$00.00%−12,147−100.0%Sold out
Oxford Asset Management LLP0$00.00%−12,143−100.0%Sold out
Ameriprise Financial Inc0$00.00%−11,440−100.0%Sold out
Two Sigma Investments, LP0$00.00%−11,299−100.0%Sold out
Raymond James Financial Inc0$00.00%−8,504−100.0%Sold out
IFP Advisors, Inc0$00.00%0Sold out
Caitong International Asset Management Co., Ltd0$00.00%−784−100.0%Sold out
Skopos Labs, Inc.0$00.00%−395−100.0%Sold out
CIBC World Markets Corp––––Not filed